11/20/2018Ascletis and Roche Enter Exclusive Pegasys Partnership in China for Vi...

11/20/2018Sanofi China to Open New $114M Research Site in Suzhou

11/20/2018NMPA Issues Notice for Implementation of State Council’s “Permit and...

11/20/2018Alphamab raises $100M in Series A financing from US, Asian investors

11/19/2018Huadong Medicine Completes Acquisition of U.K.'s Sinclair Pharma

11/19/2018CASI Pharmaceuticals To Build GMP Manufacturing Site In Wuxi

11/19/2018CCDRC Approves Plan for National Centralized Drug Purchase Trial

11/19/2018NH Reports on Chinese OTC Eye Care Market in MAT 09/2018

11/19/2018Eli Lilly Mulls Sale of Certain Off-patent CNS and Antibiotic Assets i...

11/16/2018NMPA Approves Gilead's Vemlidy (Tenofovir Alafenamide) in China

11/16/2018Chi-Med Announces Negative Results of Phase III Chinese Trial for Fruq...

11/16/2018NMPA Grants Priority Review to BeiGene's NDAs for Zanubrutinib and Tis...

11/15/2018How China Will Handle Its Trade War With the United States in 2019

11/15/2018MorphoSys and I-Mab Enter Strategic Alliance for MorphoSys's Novel I/O...

11/15/2018Catalent Invests in Its 2nd Clinical Supply Facility in Shanghai

11/15/2018President Xi Pledges to Protect IP and Boost Import at 1st Import Expo

11/14/2018U.S. Trade Union Urges USFDA to Investigate GNC Acquisition by Harbin ...

11/13/2018CFIUS Broadens Coverage of Cross-Border Biotech Transactions

11/13/2018China's Crackdown on Genetics Breaches Could Deter Data Sharing

11/13/2018NMPA Issues Rules for Drug Export Sales Certificate

11/12/2018Angion Biomedica and Sinovant Enter Licensing Deal to Develop AKI Drug...

11/12/2018Yifan Subsidiary Announces Chinese IND Approval of Anticaner A-319

11/12/2018Innovent Files Chinese NDA for Humira Biosimilar IBI303

11/12/2018In China, Desperate Patients Smuggle Drugs. Or Make Their Own.

11/12/2018Merck to Quadruple Gardasil Supply in China to Meet Fast-rising Demand

11/12/2018Leading MNCs Tout Renewed China Business Growth in Q3

11/12/2018BeiGene Delays US Filing for BTK Inhibitor Zanubrutinib

11/12/2018Eisai Launches HCC Drug LENVIMA (lenvatinib) in China

11/12/2018SAMR Solicits Comments on Vaccine Administration Law

11/12/2018SAMR Solicits Comments on Production Licensing Regulation for Formulat...

Page:304/776 Total number of articles:23255: [First][<<] [302] [303] [304] [305] [306] [>>] [End]